Once-daily, single-inhaler indacaterol/mometasone versus twice-daily salmeterol/fluticasone in Asian patients with inadequately controlled asthma: post hoc pooled analysis from PALLADIUM and IRIDIUM studies.

Yasuhiro Gon,Tsuyoshi Ishii,David Lawrence,Ivan Nikolaev,Dong Wang,Kazuya Sumi,Yoichi Nakamura

Once-daily, single-inhaler indacaterol/mometasone versus twice-daily salmeterol/fluticasone in Asian patients with inadequately controlled asthma: post hoc pooled analysis from PALLADIUM and IRIDIUM studies.

2021

Yasuhiro Gon
Tsuyoshi Ishii
David Lawrence
Ivan Nikolaev
Dong Wang
Kazuya Sumi
Yoichi Nakamura

PALLADIUM and IRIDIUM studies demonstrated efficacy and safety of indacaterol/mometasone (IND/MF) versus salmeterol/fluticasone (SAL/FLU). This post hoc analysis of pooled data from PALLADIUM and I...

Keywords:

Inhaler
Fluticasone
Mometasone
Salmeterol
Medicine
Indacaterol
Palladium
Internal medicine
Asthma
Post-hoc analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations